~~<i id='79B0551851'><strike id='79B0551851'><tt id='79B0551851'><pre id='79B0551851'></pre></tt></strike></i>~~

Home» Wikipedia» hotspot

hotspot

author：Wikipedia 2025-09-28 17:33:57 Page View：73128

HHS 2020 — PhRMA is suing the Biden administration over its new Medicare drug price negotiation program. Graeme Sloan/Sipa USA

WASHINGTON — After losing the drug pricing fight on Capitol Hill, PhRMA is taking its battle to the courts.

The pharmaceutical industry’s biggest lobbying group on Wednesday filed a long-expected lawsuit challenging Democrats’ drug pricing law that allowed Medicare to start negotiating prices for certain medicines.

PhRMA joins a growing club of companies and trades challenging the law. Merck, Bristol Myers Squibb, and the Chamber of Commerce have already filed similar suits in different courts.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Finland to offer bird flu vaccine to select groups of people, a possible global first
Next article： BioMarin wins approval for gene therapy to treat hemophilia A

explore

DIEP, the 'gold standard' of breast reconstruction, is under threat

AdobeIn1983,Iflewhomefromcollegetobewithmymotherasshewokeupfromamastectomy.Sheoptedoutofbreastrecons

Eli Lilly’s Zepbound improved liver scarring in mid

Illustration:STAT;Source:EliLilly/APEliLilly’sblockbusterdiabetesandobesitydrugimprovedlivingscarrin

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

In new study, freeze

Nucleifrommousecellsthatwerefreeze-driedbeinginjectedintomouseeggcells.UniversityofYamanashiTwoyears